Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
26 May 2021
Historique:
received: 30 03 2021
revised: 22 04 2021
accepted: 22 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 11 8 2021
Statut: epublish

Résumé

Cystic Fibrosis (CF) is a life-long genetic disease, causing increased energy needs and a healthy diet with a specific nutrient distribution. Nutritional status is an indicator of disease prognosis and survival. This study aimed at assessing the effectiveness of a self-management mobile app in supporting patients with CF to achieve the dietary goals set by the CF nutrition guidelines. A clinical trial was conducted in pancreatic insufficient children with CF, followed in six European CF centres, where the self-management app developed within the MyCyFAPP project was used for six months. To assess secondary outcomes, three-day food records were compiled in the app at baseline and after 3 and 6 months of use. Eighty-four subjects (mean 7.8 years old) were enrolled. Compared to baseline, macronutrient distribution better approximated the guidelines, with protein and lipid increasing by 1.0 and 2.1% of the total energy intake, respectively, by the end of the study. Consequently, carbohydrate intake of the total energy intake decreased significantly (-2.9%), along with simple carbohydrate intake (-2.4%). Regarding food groups, a decrease in ultra-processed foods was documented, with a concomitant increase in meat and dairy. The use of a self-management mobile app to self-monitor dietary intake could become a useful tool to achieve adherence to guideline recommendations, if validated during a longer period of time or against a control group.

Identifiants

pubmed: 34073260
pii: nu13061801
doi: 10.3390/nu13061801
pmc: PMC8229611
pii:
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Horizon 2020 Framework Programme
ID : 643806

Références

J Acad Nutr Diet. 2019 Aug;119(8):1305-1319
pubmed: 30862484
BMJ Open. 2017 Mar 16;7(3):e014931
pubmed: 28302638
J Cyst Fibros. 2018 Nov;17(6):804-810
pubmed: 29724576
J Cyst Fibros. 2002 Jun;1(2):51-75
pubmed: 15463811
J Clin Epidemiol. 1988;41(6):583-91
pubmed: 3260274
Expert Opin Emerg Drugs. 2014 Mar;19(1):143-55
pubmed: 24479826
J Cyst Fibros. 2020 Jul;19(4):562-568
pubmed: 32335023
Am J Hypertens. 2017 Apr 1;30(4):358-366
pubmed: 27927627
Dig Liver Dis. 2014 Oct;46(10):865-74
pubmed: 25053610
Science. 2003 Feb 7;299(5608):853-5
pubmed: 12574618
Clin Nutr. 2014 Jun;33(3):528-32
pubmed: 23920501
JMIR Mhealth Uhealth. 2020 Jul 8;8(7):e15896
pubmed: 32673237
J Am Diet Assoc. 2008 May;108(5):847-52
pubmed: 18442509
J Cyst Fibros. 2013 Mar;12(2):102-15
pubmed: 23232324
J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):355-60
pubmed: 25782658
J Cyst Fibros. 2020 Dec 2;:
pubmed: 33279468
Eur J Nutr. 2020 Apr;59(3):979-989
pubmed: 30949765
Nutr Metab Cardiovasc Dis. 2019 Jun;29(6):544-560
pubmed: 31078365
J Pediatr. 2013 Mar;162(3):530-535.e1
pubmed: 23062247
PLoS One. 2019 Feb 22;14(2):e0212459
pubmed: 30794618
Arch Pediatr Adolesc Med. 2009 Oct;163(10):915-21
pubmed: 19805710
Clin Nutr. 2016 Jun;35(3):557-77
pubmed: 27068495

Auteurs

Joaquim Calvo-Lerma (J)

Instituto de Investigación Sanitaria La Fe-Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.

Mieke Boon (M)

Center for Cystic Fibrosis, Department of Pediatrics, University Hospital Leuven, 3000 Leuven, Belgium.

Jessie Hulst (J)

Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

Carla Colombo (C)

Cystic Fibrosis Center, University of Milan, IRCCS Ca 'Granda, Maggiore Policlinico Hospital, 20122 Milan, Italy.

Inês Asseiceira (I)

Centro de Fibrose Quística, Hospital de Santa Maria, 1649-028 Lisbon, Portugal.

María Garriga (M)

Unidad de Fibrosis Quística, Hospital Universitario Ramón y Cajal, 28010 Madrid, Spain.

Etna Masip (E)

Instituto de Investigación Sanitaria La Fe-Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.

Ine Claes (I)

Center for Cystic Fibrosis, Department of Pediatrics, University Hospital Leuven, 3000 Leuven, Belgium.

Anna Bulfamante (A)

Cystic Fibrosis Center, University of Milan, IRCCS Ca 'Granda, Maggiore Policlinico Hospital, 20122 Milan, Italy.

Hettie M Janssens (HM)

Department of Pediatrics, Division of Gastro-Enterology, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, 14010 Rotterdam, The Netherlands.
Department of Pediatrics, Division of Respiratory Medicine and Allergology, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, 14010 Rotterdam, The Netherlands.

Maria Roca (M)

Instituto de Investigación Sanitaria La Fe-Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.

Saioa Vicente (S)

Unidad de Fibrosis Quística, Hospital Universitario Ramón y Cajal, 28010 Madrid, Spain.

Victoria Fornés (V)

Tauceramica Analytics, 46980 Paterna, Spain.

Laura Zazzeron (L)

Cystic Fibrosis Center, University of Milan, IRCCS Ca 'Granda, Maggiore Policlinico Hospital, 20122 Milan, Italy.

Bo van Schijndel (B)

Department of Pediatrics, Division of Gastro-Enterology, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, 14010 Rotterdam, The Netherlands.
Department of Pediatrics, Division of Respiratory Medicine and Allergology, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, 14010 Rotterdam, The Netherlands.

Sandra Woodcock (S)

Department of Pediatrics, Division of Gastro-Enterology, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, 14010 Rotterdam, The Netherlands.
Department of Pediatrics, Division of Respiratory Medicine and Allergology, Erasmus MC-Sophia Children's Hospital, University Hospital Rotterdam, 14010 Rotterdam, The Netherlands.

Luisa Pereira (L)

Centro de Fibrose Quística, Hospital de Santa Maria, 1649-028 Lisbon, Portugal.

Kris de Boeck (K)

Center for Cystic Fibrosis, Department of Pediatrics, University Hospital Leuven, 3000 Leuven, Belgium.

Carmen Ribes-Koninckx (C)

Instituto de Investigación Sanitaria La Fe-Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH